| ID . | Position . | Sequence . | Tested HLA . | Actual HLA restriction . | ELISpot response rate (%) . | Intracellular staining . | Tetramer staining . | |
|---|---|---|---|---|---|---|---|---|
| 12-d stimulation . | Ex vivoa . | |||||||
| MRC-5 | ||||||||
| UL83495–503 | 495–503 | NLVPMVATVb | A*02:01 | A*02:01 | 21/28 (75.0) | 100.0 | CD8 | Positive |
| US874–82 | 74–82 | GVLDAVWRV | A*02:01 | A*02:01 | 13/18 (72.2) | 50.0 | CD8 | Positive |
| UL150A152–161 | 152–161 | ALWDVALLEV | A*02:01 | A*02:01 | 10/14 (71.4) | 25.0 | CD8 | Positive |
| UL100200–208 | 200–208 | TLIVNLVEV | A*02:01 | A*02:01 | 11/20 (55.0) | 25.0 | CD8 | Positive |
| UL44259–267 | 259–267 | GLFAVENFL | A*02:01 | DR | 7/13 (53.9) | 0.0 | CD4 | nt |
| UL7140–48 | 40–48 | FLDENFKQL | A*02:01 | DR | 10/21 (47.6) | 37.5 | CD4 | Negative |
| UL105431–439 | 431–439 | RLFDLPVYC | A*02:01 | 5/12 (41.7) | nt | nt | nt | |
| UL147A2–10 | 2–10 | SLFYRAVAL | A*02:01 | 5/13 (38.5) | 12.5 | nt | nt | |
| UL29175–183 | 175–183 | RLQPNVPLV | A*02:01 | 6/18 (33.3) | 0.0 | nt | nt | |
| US16134–144 | 134–144 | GLLAHIPALGV | A*02:01 | 6/22 (27.3) | 0.0 | nt | nt | |
| US29293–301 | 293–301 | ALSPSTSKV | A*02:01 | 4/17 (23.5) | nt | nt | nt | |
| UL29344–352 | 344–352 | SLYEANPEL | A*02:01 | 4/17 (23.5) | nt | nt | nt | |
| UL86146–154 | 146–154 | TILDKILNV | A*02:01 | 4/20 (20.0) | nt | nt | nt | |
| US16186–194 | 186–194 | TLINGVWVV | A*02:01 | 2/11 (18.2) | nt | nt | nt | |
| US16134–142 | 134–142 | GLLAHIPAL | A*02:01 | 2/11 (18.2) | nt | nt | nt | |
| UL48132–141 | 132–141 | ALYPEYIYTV | A*02:01 | 3/18 (16.7) | nt | nt | nt | |
| UL47766–744 | 766–774 | GLNERLLSV | A*02:01 | 3/20 (15.0) | nt | nt | nt | |
| UL34130–138 | 130–138 | ALFNQLVFTA | A*02:01 | 2/15 (13.3) | nt | nt | nt | |
| UL56124–132 | 124–132 | FTDNVRFSV | A*02:01 | 1/13 (7.8) | nt | nt | nt | |
| UL128145–153 | 145–153 | GLDQYLESV | A*02:01 | 1/13 (7.8) | nt | nt | nt | |
| UL84133–141 | 133–141 | ALLGRLYFI | A*02:01 | 1/15 (6.7) | nt | nt | nt | |
| UL496–104 | 96–104 | NYNEQHYRY | A*29:02 | 5/13 (38.5) | nt | nt | nt | |
| US27276–284 | 276–284 | LYVGQFLAY | A*29:02 | 3/12 (25.0) | nt | nt | nt | |
| UL488–97 | 88–97 | SFFPKLQGNY | A*29:02 | 2/9 (22.2) | nt | nt | nt | |
| UL489–97 | 89–97 | FFPKLQGNY | A*29:02 | 2/12 (16.7) | nt | nt | nt | |
| UL16162–170 | 162–170 | YPRPPGSGLc | B*07:02 | B*07:02 | 19/22 (86.4) | 25.0 | Negative | Positive |
| UL83417–426 | 417–426 | TPRVTGGGAMd | B*07:02 | B*07:02 | 31/38 (81.6) | 100.0 | CD8 | Positive |
| TRS1166–174 | 166–174 | SPRDAWIVL | B*07:02 | B*07:02 | 15/22 (68.2) | 20.0 | CD8 | Positive |
| UL52349–357 | 349–357 | SPSRDRFVQL | B*07:02 | B*07:02 | 14/21 (66.7) | 33.3 | Negative | Positive |
| UL2322–30 | 22–30 | RPWKPGQRV | B*07:02 | B*07:02 | 15/28 (53.6) | 66.7 | CD8 | Positive |
| UL4676–84 | 76–84 | SPRHLYISL | B*07:02 | B*07:02 | 11/22 (50.0) | 0.0 | CD4/CD8 | Positive |
| UL38225–235 | 225–235 | IPMTFVDRDSL | B*07:02 | 5/14 (35.7) | nt | nt | nt | |
| US30313–321 | 313–321 | RPFPSTHQL | B*07:02 | 4/13 (30.8) | 0.0 | nt | nt | |
| UL8349–57 | 49–57 | RVSQPSLIL | B*07:02 | 4/15 (26.7) | nt | nt | nt | |
| UL34180–188 | 180–188 | LPHERHREL | B*07:02 | 3/12 (25.0) | nt | nt | nt | |
| UL82245–254 | 245–254 | SPHPPTSVFL | B*07:02 | 3/12 (25.0) | nt | nt | nt | |
| UL27485–493 | 485–493 | IPDYRSVSL | B*07:02 | 4/18 (22.2) | nt | nt | nt | |
| UL31310–317 | 310–317 | APFGRVSV | B*07:02 | 3/15 (20.0) | nt | nt | nt | |
| TRS1/IRS192–99 | 92–99 | IPVERQAL | B*07:02 | 2/12 (16.7) | nt | nt | nt | |
| UL98135–143 | 135–143 | APNYRQVEL | B*07:02 | 2/12 (16.7) | nt | nt | nt | |
| UL40210–218 | 210–218 | LPNDHHYAL | B*07:02 | 1/17 (5.9) | nt | nt | nt | |
| US1282–89 | 82–89 | APYLRDTL | B*07:02 | 1/19 (5.3) | nt | nt | nt | |
| UL112/UL113125–134 | 125–134 | SENGNLQVTY | B*44:02 | B*44:02 | 26/31 (83.9) | 62.5 | CD8 | Positive |
| UL117358–366 | 358–366 | HETGVYQMW | B*44:02 | B*44:02 | 17/26 (65.4) | 62.5 | CD8 | Positive |
| UL1724–32 | 24–32 | DEQVSKRSW | B*44:02 | B*44:02 | 11/24 (45.8) | 12.5 | CD8 | Positive |
| TRL12402–410 | 402–410 | SESEFIVRY | B*44:02 | B*44:02 | 8/20 (40.0) | 37.5 | CD8 | Positive |
| UL147A51–59 | 51–59 | EEQDYRALL | B*44:02 | 4/12 (33.3) | nt | nt | nt | |
| UL78150–158 | 150–158 | RENAGVALY | B*44:02 | 4/21 (19.1) | nt | nt | nt | |
| US2171–80 | 71–80 | AEPNFPKNVW | B*44:02 | 2/14 (14.3) | nt | nt | nt | |
| TRS1/IRS1276–285 | 276–285 | EEATALGREL | B*44:02 | 1/10 (10.0) | nt | nt | nt | |
| US11103–111 | 103–111 | SESLVAKRY | B*44:02 | 1/10 (10.0) | nt | nt | nt | |
| UL54755–763 | 755–763 | LENGVTHRF | B*44:02 | 1/14 (7.1) | nt | nt | nt | |
| US2272–81 | 72–81 | REQAAIPQIY | B*44:02 | 1/16 (6.3) | nt | nt | nt | |
| UL57640–648 | 640–648 | FVDDEALGF | C*05:01 | 2/11 (18.2) | nt | nt | nt | |
| HF–99/7 | ||||||||
| UL105715–723 | 715–723 | YADPFFLKYe | A*01:01 | A*01:01 | 15/15 (100.0) | 90.9 | CD8 | Positive |
| UL44245–253 | 245–253 | VTEHDTLLYc | A*01:01 | A*01:01 | 13/14 (92.9) | 100.0 | CD8 | Positive |
| UL69569–578 | 569–578 | RTDPATLTAY | A*01:01 | A*01:01 | 19/23 (82.6) | 66.7 | CD8 | Positive |
| US28122–130 | 122–130 | ITEIALDRY | A*01:01 | A*01:01 | 14/24 (58.3) | 14.3 | CD8 | Positive |
| UL55657–665 | 657–666 | NTDFRVLELY | A*01:01 | A*01:01 | 9/16 (56.3) | 0.0 | CD8 | Positive |
| UL3682–91 | 82–91 | FVEGPGFMRY | A*01:01 | 5/14 (35.7) | nt | nt | ||
| UL148282–290 | 282–290 | SLDRFIVQY | A*01:01 | DR | 5/14 (35.7) | CD4 | nt | |
| UL25370–379 | 370–379 | YTSRGALYLY | A*01:01 | 3/14 (21.4) | nt | nt | ||
| UL861346–1354 | 1,346–1,354 | TSETHFGNY | A*01:01 | 3/15 (20.0) | nt | nt | ||
| US3492–101 | 92–101 | GSDALPAGLY | A*01:01 | 3/16 (18.8) | nt | nt | ||
| UL481607–1617 | 1,607–1,617 | VTDYGNVAFKY | A*01:01 | 3/16 (18.8) | nt | nt | ||
| IRS1/TRS1464–474 | 464–474 | LLDELGAVFGY | A*01:01 | 2/13 (15.4) | nt | nt | ||
| UL112/UL113124–134 | 124–134 | ISENGNLQVTY | A*01:01 | 3/20 (15.0) | nt | nt | ||
| UL105616–624 | 916–924 | VTDPEHLMM | A*01:01 | 2/14 (14.3) | nt | nt | ||
| UL105360–369 | 360–369 | DLDFGDLLKY | A*01:01 | 2/16 (12.5) | nt | nt | ||
| UL78222–232 | 222–232 | YSDRRDHVWSY | A*01:01 | 1/16 (6.3) | nt | nt | ||
| UL77228–236 | 228–236 | GLYTQPRWK | A*03:01 | A*03:01 | 16/21 (76.2) | 50.0 | CD8 | Positive |
| UL57790–798 | 790–798 | RVKNRPIYR | A*03:01 | A*03:01 | 14/23 (60.9) | 33.3 | CD8 | Positive |
| UL3651–60 | 51–60 | RSALGPFVGK | A*03:01 | A*03:01 | 6/15 (40.0) | CD8 | Positive | |
| UL123184–192 | 184–192 | KLGGALQAKf | A*03:01 | 6/15 (40.0) | nt | nt | ||
| US33A13–21 | 13–21 | KLGYRPHAK | A*03:01 | A*03:01 | 11/29 (37.9) | CD8 | Positive | |
| US24136–145 | 136–145 | RVYAYDTREK | A*03:01 | 4/11 (36.4) | nt | nt | ||
| UL25580–588 | 580–588 | GVSSVTLLK | A*03:01 | 5/14 (35.7) | nt | nt | ||
| UL843–11 | 3–11 | RVDPNLRNR | A*03:01 | 5/15 (33.3) | nt | nt | ||
| UL70698–706 | 698–706 | SVRLPYMYK | A*03:01 | 4/16 (25.0) | nt | nt | ||
| UL79237–245 | 237–245 | RTFAGTLSR | A*03:01 | 3/14 (21.4) | nt | nt | ||
| UL571044–1052 | 1,044–1,052 | RLADVLIKR | A*03:01 | 2/13 (15.4) | nt | nt | ||
| UL70697–706 | 697–706 | RSVRLPYMYK | A*03:01 | 2/15 (13.3) | nt | nt | ||
| UL122113–121 | 113–121 | SVSSAPLNK | A*03:01 | 1/14 (7.1) | nt | nt | ||
| UL34180–188 | 180–188 | LPHERHREL | B*08:01 | B*08:01 | 20/22 (90.9) | 85.7 | CD8 | Positive |
| UL2661–69 | 61–69 | LPYPRGYTL | B*08:01 | B*08:01/ B*51:01 | 11/16 (68.8) | 16.7 | CD8 | Positive |
| UL13465–473 | 465–473 | YLVRRPMTI | B*08:01 | B*08:01 | 11/22 (50.0) | 33.3 | Negative | Positive |
| UL36199–207 | 199–207 | VMKFKETSF | B*08:01 | 5/13 (38.5) | nt | nt | ||
| UL84239–247 | 239–247 | TPLLKRLPL | B*08:01 | 4/14 (28.6) | nt | nt | ||
| UL40170–178 | 170–178 | HLKLRPATF | B*08:01 | 3/13 (23.1) | nt | nt | ||
| UL84500–507 | 500–507 | FISSKHTL | B*08:01 | 3/14 (21.4) | nt | nt | ||
| UL147A2–10 | 2–10 | SLFYRAVAL | B*08:01 | 4/22 (18.2) | nt | nt | ||
| UL4426–34 | 26–34 | QLRSVIRAL | B*08:01 | 2/14 (14.3) | nt | nt | ||
| UL1481–8 | 1–8 | MLRLLFTL | B*08:01 | 1/14 (7.1) | nt | nt | ||
| UL83116–123 | 116–123 | LPLKMLNIg | B*51:01 | B*51:01 | 12/15 (80.0) | 87.5 | CD8 | Positive |
| UL38156–164 | 156–164 | FPVEVRSHV | B*51:01 | B*51:01 | 15/23 (65.2) | 0.0 | CD8 | Positive |
| UL2661–69 | 61–69 | LPYPRGYTL | B*51:01 | B*08:01/B*51:01 | 10/16 (62.5) | 33.3 | CD8 | Positive |
| UL56503–511 | 503–511 | DARSRIHNV | B*51:01 | B*51:01 | 8/15 (53.3) | CD8 | Positive | |
| UL71330–338 | 330–338 | IPPPQIPFV | B*51:01 | 6/15 (40.0) | nt | nt | ||
| US28158–166 | 158–166 | IAIPHFMVV | B*51:01 | 5/15 (33.3) | nt | nt | ||
| US2365–73 | 65–73 | IPHNWFLQV | B*51:01 | 5/15 (33.3) | nt | nt | ||
| UL33162–170 | 162–170 | VPAAVYTTV | B*51:01 | 5/15 (33.3) | nt | nt | ||
| UL1466–74 | 66–74 | FPAHDWPEV | B*51:01 | 2/15 (13.3) | nt | nt | ||
| UL122449–457 | 449–457 | MPVTHPPEV | B*51:01 | 2/15 (13.3) | nt | nt | ||
| UL75540–549 | 540–549 | FPDATVPATV | B*51:01 | 1/15 (6.7) | nt | nt | ||
| UL481322–1331 | 1,322–1,331 | LPYLSAERTV | B*51:01 | 1/15 (6.7) | nt | nt | ||
| UL78335–343 | 335–343 | KRAMYSVEL | C*07:01 | 2/15 (13.3) | nt | nt | ||
| ID . | Position . | Sequence . | Tested HLA . | Actual HLA restriction . | ELISpot response rate (%) . | Intracellular staining . | Tetramer staining . | |
|---|---|---|---|---|---|---|---|---|
| 12-d stimulation . | Ex vivoa . | |||||||
| MRC-5 | ||||||||
| UL83495–503 | 495–503 | NLVPMVATVb | A*02:01 | A*02:01 | 21/28 (75.0) | 100.0 | CD8 | Positive |
| US874–82 | 74–82 | GVLDAVWRV | A*02:01 | A*02:01 | 13/18 (72.2) | 50.0 | CD8 | Positive |
| UL150A152–161 | 152–161 | ALWDVALLEV | A*02:01 | A*02:01 | 10/14 (71.4) | 25.0 | CD8 | Positive |
| UL100200–208 | 200–208 | TLIVNLVEV | A*02:01 | A*02:01 | 11/20 (55.0) | 25.0 | CD8 | Positive |
| UL44259–267 | 259–267 | GLFAVENFL | A*02:01 | DR | 7/13 (53.9) | 0.0 | CD4 | nt |
| UL7140–48 | 40–48 | FLDENFKQL | A*02:01 | DR | 10/21 (47.6) | 37.5 | CD4 | Negative |
| UL105431–439 | 431–439 | RLFDLPVYC | A*02:01 | 5/12 (41.7) | nt | nt | nt | |
| UL147A2–10 | 2–10 | SLFYRAVAL | A*02:01 | 5/13 (38.5) | 12.5 | nt | nt | |
| UL29175–183 | 175–183 | RLQPNVPLV | A*02:01 | 6/18 (33.3) | 0.0 | nt | nt | |
| US16134–144 | 134–144 | GLLAHIPALGV | A*02:01 | 6/22 (27.3) | 0.0 | nt | nt | |
| US29293–301 | 293–301 | ALSPSTSKV | A*02:01 | 4/17 (23.5) | nt | nt | nt | |
| UL29344–352 | 344–352 | SLYEANPEL | A*02:01 | 4/17 (23.5) | nt | nt | nt | |
| UL86146–154 | 146–154 | TILDKILNV | A*02:01 | 4/20 (20.0) | nt | nt | nt | |
| US16186–194 | 186–194 | TLINGVWVV | A*02:01 | 2/11 (18.2) | nt | nt | nt | |
| US16134–142 | 134–142 | GLLAHIPAL | A*02:01 | 2/11 (18.2) | nt | nt | nt | |
| UL48132–141 | 132–141 | ALYPEYIYTV | A*02:01 | 3/18 (16.7) | nt | nt | nt | |
| UL47766–744 | 766–774 | GLNERLLSV | A*02:01 | 3/20 (15.0) | nt | nt | nt | |
| UL34130–138 | 130–138 | ALFNQLVFTA | A*02:01 | 2/15 (13.3) | nt | nt | nt | |
| UL56124–132 | 124–132 | FTDNVRFSV | A*02:01 | 1/13 (7.8) | nt | nt | nt | |
| UL128145–153 | 145–153 | GLDQYLESV | A*02:01 | 1/13 (7.8) | nt | nt | nt | |
| UL84133–141 | 133–141 | ALLGRLYFI | A*02:01 | 1/15 (6.7) | nt | nt | nt | |
| UL496–104 | 96–104 | NYNEQHYRY | A*29:02 | 5/13 (38.5) | nt | nt | nt | |
| US27276–284 | 276–284 | LYVGQFLAY | A*29:02 | 3/12 (25.0) | nt | nt | nt | |
| UL488–97 | 88–97 | SFFPKLQGNY | A*29:02 | 2/9 (22.2) | nt | nt | nt | |
| UL489–97 | 89–97 | FFPKLQGNY | A*29:02 | 2/12 (16.7) | nt | nt | nt | |
| UL16162–170 | 162–170 | YPRPPGSGLc | B*07:02 | B*07:02 | 19/22 (86.4) | 25.0 | Negative | Positive |
| UL83417–426 | 417–426 | TPRVTGGGAMd | B*07:02 | B*07:02 | 31/38 (81.6) | 100.0 | CD8 | Positive |
| TRS1166–174 | 166–174 | SPRDAWIVL | B*07:02 | B*07:02 | 15/22 (68.2) | 20.0 | CD8 | Positive |
| UL52349–357 | 349–357 | SPSRDRFVQL | B*07:02 | B*07:02 | 14/21 (66.7) | 33.3 | Negative | Positive |
| UL2322–30 | 22–30 | RPWKPGQRV | B*07:02 | B*07:02 | 15/28 (53.6) | 66.7 | CD8 | Positive |
| UL4676–84 | 76–84 | SPRHLYISL | B*07:02 | B*07:02 | 11/22 (50.0) | 0.0 | CD4/CD8 | Positive |
| UL38225–235 | 225–235 | IPMTFVDRDSL | B*07:02 | 5/14 (35.7) | nt | nt | nt | |
| US30313–321 | 313–321 | RPFPSTHQL | B*07:02 | 4/13 (30.8) | 0.0 | nt | nt | |
| UL8349–57 | 49–57 | RVSQPSLIL | B*07:02 | 4/15 (26.7) | nt | nt | nt | |
| UL34180–188 | 180–188 | LPHERHREL | B*07:02 | 3/12 (25.0) | nt | nt | nt | |
| UL82245–254 | 245–254 | SPHPPTSVFL | B*07:02 | 3/12 (25.0) | nt | nt | nt | |
| UL27485–493 | 485–493 | IPDYRSVSL | B*07:02 | 4/18 (22.2) | nt | nt | nt | |
| UL31310–317 | 310–317 | APFGRVSV | B*07:02 | 3/15 (20.0) | nt | nt | nt | |
| TRS1/IRS192–99 | 92–99 | IPVERQAL | B*07:02 | 2/12 (16.7) | nt | nt | nt | |
| UL98135–143 | 135–143 | APNYRQVEL | B*07:02 | 2/12 (16.7) | nt | nt | nt | |
| UL40210–218 | 210–218 | LPNDHHYAL | B*07:02 | 1/17 (5.9) | nt | nt | nt | |
| US1282–89 | 82–89 | APYLRDTL | B*07:02 | 1/19 (5.3) | nt | nt | nt | |
| UL112/UL113125–134 | 125–134 | SENGNLQVTY | B*44:02 | B*44:02 | 26/31 (83.9) | 62.5 | CD8 | Positive |
| UL117358–366 | 358–366 | HETGVYQMW | B*44:02 | B*44:02 | 17/26 (65.4) | 62.5 | CD8 | Positive |
| UL1724–32 | 24–32 | DEQVSKRSW | B*44:02 | B*44:02 | 11/24 (45.8) | 12.5 | CD8 | Positive |
| TRL12402–410 | 402–410 | SESEFIVRY | B*44:02 | B*44:02 | 8/20 (40.0) | 37.5 | CD8 | Positive |
| UL147A51–59 | 51–59 | EEQDYRALL | B*44:02 | 4/12 (33.3) | nt | nt | nt | |
| UL78150–158 | 150–158 | RENAGVALY | B*44:02 | 4/21 (19.1) | nt | nt | nt | |
| US2171–80 | 71–80 | AEPNFPKNVW | B*44:02 | 2/14 (14.3) | nt | nt | nt | |
| TRS1/IRS1276–285 | 276–285 | EEATALGREL | B*44:02 | 1/10 (10.0) | nt | nt | nt | |
| US11103–111 | 103–111 | SESLVAKRY | B*44:02 | 1/10 (10.0) | nt | nt | nt | |
| UL54755–763 | 755–763 | LENGVTHRF | B*44:02 | 1/14 (7.1) | nt | nt | nt | |
| US2272–81 | 72–81 | REQAAIPQIY | B*44:02 | 1/16 (6.3) | nt | nt | nt | |
| UL57640–648 | 640–648 | FVDDEALGF | C*05:01 | 2/11 (18.2) | nt | nt | nt | |
| HF–99/7 | ||||||||
| UL105715–723 | 715–723 | YADPFFLKYe | A*01:01 | A*01:01 | 15/15 (100.0) | 90.9 | CD8 | Positive |
| UL44245–253 | 245–253 | VTEHDTLLYc | A*01:01 | A*01:01 | 13/14 (92.9) | 100.0 | CD8 | Positive |
| UL69569–578 | 569–578 | RTDPATLTAY | A*01:01 | A*01:01 | 19/23 (82.6) | 66.7 | CD8 | Positive |
| US28122–130 | 122–130 | ITEIALDRY | A*01:01 | A*01:01 | 14/24 (58.3) | 14.3 | CD8 | Positive |
| UL55657–665 | 657–666 | NTDFRVLELY | A*01:01 | A*01:01 | 9/16 (56.3) | 0.0 | CD8 | Positive |
| UL3682–91 | 82–91 | FVEGPGFMRY | A*01:01 | 5/14 (35.7) | nt | nt | ||
| UL148282–290 | 282–290 | SLDRFIVQY | A*01:01 | DR | 5/14 (35.7) | CD4 | nt | |
| UL25370–379 | 370–379 | YTSRGALYLY | A*01:01 | 3/14 (21.4) | nt | nt | ||
| UL861346–1354 | 1,346–1,354 | TSETHFGNY | A*01:01 | 3/15 (20.0) | nt | nt | ||
| US3492–101 | 92–101 | GSDALPAGLY | A*01:01 | 3/16 (18.8) | nt | nt | ||
| UL481607–1617 | 1,607–1,617 | VTDYGNVAFKY | A*01:01 | 3/16 (18.8) | nt | nt | ||
| IRS1/TRS1464–474 | 464–474 | LLDELGAVFGY | A*01:01 | 2/13 (15.4) | nt | nt | ||
| UL112/UL113124–134 | 124–134 | ISENGNLQVTY | A*01:01 | 3/20 (15.0) | nt | nt | ||
| UL105616–624 | 916–924 | VTDPEHLMM | A*01:01 | 2/14 (14.3) | nt | nt | ||
| UL105360–369 | 360–369 | DLDFGDLLKY | A*01:01 | 2/16 (12.5) | nt | nt | ||
| UL78222–232 | 222–232 | YSDRRDHVWSY | A*01:01 | 1/16 (6.3) | nt | nt | ||
| UL77228–236 | 228–236 | GLYTQPRWK | A*03:01 | A*03:01 | 16/21 (76.2) | 50.0 | CD8 | Positive |
| UL57790–798 | 790–798 | RVKNRPIYR | A*03:01 | A*03:01 | 14/23 (60.9) | 33.3 | CD8 | Positive |
| UL3651–60 | 51–60 | RSALGPFVGK | A*03:01 | A*03:01 | 6/15 (40.0) | CD8 | Positive | |
| UL123184–192 | 184–192 | KLGGALQAKf | A*03:01 | 6/15 (40.0) | nt | nt | ||
| US33A13–21 | 13–21 | KLGYRPHAK | A*03:01 | A*03:01 | 11/29 (37.9) | CD8 | Positive | |
| US24136–145 | 136–145 | RVYAYDTREK | A*03:01 | 4/11 (36.4) | nt | nt | ||
| UL25580–588 | 580–588 | GVSSVTLLK | A*03:01 | 5/14 (35.7) | nt | nt | ||
| UL843–11 | 3–11 | RVDPNLRNR | A*03:01 | 5/15 (33.3) | nt | nt | ||
| UL70698–706 | 698–706 | SVRLPYMYK | A*03:01 | 4/16 (25.0) | nt | nt | ||
| UL79237–245 | 237–245 | RTFAGTLSR | A*03:01 | 3/14 (21.4) | nt | nt | ||
| UL571044–1052 | 1,044–1,052 | RLADVLIKR | A*03:01 | 2/13 (15.4) | nt | nt | ||
| UL70697–706 | 697–706 | RSVRLPYMYK | A*03:01 | 2/15 (13.3) | nt | nt | ||
| UL122113–121 | 113–121 | SVSSAPLNK | A*03:01 | 1/14 (7.1) | nt | nt | ||
| UL34180–188 | 180–188 | LPHERHREL | B*08:01 | B*08:01 | 20/22 (90.9) | 85.7 | CD8 | Positive |
| UL2661–69 | 61–69 | LPYPRGYTL | B*08:01 | B*08:01/ B*51:01 | 11/16 (68.8) | 16.7 | CD8 | Positive |
| UL13465–473 | 465–473 | YLVRRPMTI | B*08:01 | B*08:01 | 11/22 (50.0) | 33.3 | Negative | Positive |
| UL36199–207 | 199–207 | VMKFKETSF | B*08:01 | 5/13 (38.5) | nt | nt | ||
| UL84239–247 | 239–247 | TPLLKRLPL | B*08:01 | 4/14 (28.6) | nt | nt | ||
| UL40170–178 | 170–178 | HLKLRPATF | B*08:01 | 3/13 (23.1) | nt | nt | ||
| UL84500–507 | 500–507 | FISSKHTL | B*08:01 | 3/14 (21.4) | nt | nt | ||
| UL147A2–10 | 2–10 | SLFYRAVAL | B*08:01 | 4/22 (18.2) | nt | nt | ||
| UL4426–34 | 26–34 | QLRSVIRAL | B*08:01 | 2/14 (14.3) | nt | nt | ||
| UL1481–8 | 1–8 | MLRLLFTL | B*08:01 | 1/14 (7.1) | nt | nt | ||
| UL83116–123 | 116–123 | LPLKMLNIg | B*51:01 | B*51:01 | 12/15 (80.0) | 87.5 | CD8 | Positive |
| UL38156–164 | 156–164 | FPVEVRSHV | B*51:01 | B*51:01 | 15/23 (65.2) | 0.0 | CD8 | Positive |
| UL2661–69 | 61–69 | LPYPRGYTL | B*51:01 | B*08:01/B*51:01 | 10/16 (62.5) | 33.3 | CD8 | Positive |
| UL56503–511 | 503–511 | DARSRIHNV | B*51:01 | B*51:01 | 8/15 (53.3) | CD8 | Positive | |
| UL71330–338 | 330–338 | IPPPQIPFV | B*51:01 | 6/15 (40.0) | nt | nt | ||
| US28158–166 | 158–166 | IAIPHFMVV | B*51:01 | 5/15 (33.3) | nt | nt | ||
| US2365–73 | 65–73 | IPHNWFLQV | B*51:01 | 5/15 (33.3) | nt | nt | ||
| UL33162–170 | 162–170 | VPAAVYTTV | B*51:01 | 5/15 (33.3) | nt | nt | ||
| UL1466–74 | 66–74 | FPAHDWPEV | B*51:01 | 2/15 (13.3) | nt | nt | ||
| UL122449–457 | 449–457 | MPVTHPPEV | B*51:01 | 2/15 (13.3) | nt | nt | ||
| UL75540–549 | 540–549 | FPDATVPATV | B*51:01 | 1/15 (6.7) | nt | nt | ||
| UL481322–1331 | 1,322–1,331 | LPYLSAERTV | B*51:01 | 1/15 (6.7) | nt | nt | ||
| UL78335–343 | 335–343 | KRAMYSVEL | C*07:01 | 2/15 (13.3) | nt | nt | ||